# Biommune Technologies Inc.: Form D filing

Biommune Technologies Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2015. The latest, on November 30, 2015, reports $600,000 sold of a $600,000 offering to 3 investors.

Find out what Biommune Technologies Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Biommune%20Technologies%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Biommune%20Technologies%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbiommune-technologies-inc-1659574)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Biommune%20Technologies%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Biommune%20Technologies%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fbiommune-technologies-inc-1659574)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: Suite 1780 - 400 Burrard St., Vancouver, British Columbia, Canada, V6C 3
- Phone: (778) 389-2936
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: British Columbia, Canada
- Year incorporated: 2011
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1659574

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 30, 2015 | New notice | $600,000 | $600,000 | $0 | 3 | Nov 18, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1659574/000117625615000365/0001176256-15-000365-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Karoly Nikolich | Director |  |
| Terry Pearson | Director |  |
| PATRICK W. GRAY | Executive Officer |  |
| Reinhard Gabathuler | Executive Officer |  |
| JENS BIERTUMPEL | Director |  |
| Judi Dalling | Executive Officer |  |
| Rob Hutchison | Director |  |
| Michael Hutchison | Director |  |

[Every Form D from the week of Nov 30, 2015](https://specstream.ai/data/form-d/week/2015-11-30) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Biommune Technologies Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).